{"title":"Nonparametric Path-Specific Effects on a Survival Outcome Through Multiple Time-to-Event Mediators.","authors":"Yen-Tsung Huang, Ju-Sheng Hong","doi":"10.1002/sim.10327","DOIUrl":null,"url":null,"abstract":"<p><p>A causal mediation model with multiple time-to-event mediators is exemplified by the natural course of human disease marked by sequential milestones with a time-to-event nature. For example, from hepatitis B infection to death, patients may experience intermediate events such as liver cirrhosis and liver cancer. The sequential events of hepatitis, cirrhosis, cancer, and death are susceptible to right censoring; moreover, the latter events may preclude the former events. Casting the natural course of human diseases in the framework of causal mediation modeling, we establish a model with intermediate and terminal events as the mediators and outcomes, respectively. We define the interventional analog of path-specific effects (iPSEs) as the effect of an exposure on a terminal event mediated (or not mediated) by any combination of intermediate events without parametric models. The expression of a counting process-based counterfactual hazard is derived under the sequential ignorability assumption. We employ composite nonparametric likelihood estimation to obtain maximum likelihood estimators for the counterfactual hazard and iPSEs. Our proposed estimators achieve asymptotic unbiasedness, uniform consistency, and weak convergence. Applying the proposed method, we show that hepatitis B induced mortality is mostly mediated through liver cancer and/or cirrhosis whereas hepatitis C induced mortality may be through extrahepatic diseases.</p>","PeriodicalId":21879,"journal":{"name":"Statistics in Medicine","volume":"44 3-4","pages":"e10327"},"PeriodicalIF":1.8000,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Statistics in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/sim.10327","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MATHEMATICAL & COMPUTATIONAL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
A causal mediation model with multiple time-to-event mediators is exemplified by the natural course of human disease marked by sequential milestones with a time-to-event nature. For example, from hepatitis B infection to death, patients may experience intermediate events such as liver cirrhosis and liver cancer. The sequential events of hepatitis, cirrhosis, cancer, and death are susceptible to right censoring; moreover, the latter events may preclude the former events. Casting the natural course of human diseases in the framework of causal mediation modeling, we establish a model with intermediate and terminal events as the mediators and outcomes, respectively. We define the interventional analog of path-specific effects (iPSEs) as the effect of an exposure on a terminal event mediated (or not mediated) by any combination of intermediate events without parametric models. The expression of a counting process-based counterfactual hazard is derived under the sequential ignorability assumption. We employ composite nonparametric likelihood estimation to obtain maximum likelihood estimators for the counterfactual hazard and iPSEs. Our proposed estimators achieve asymptotic unbiasedness, uniform consistency, and weak convergence. Applying the proposed method, we show that hepatitis B induced mortality is mostly mediated through liver cancer and/or cirrhosis whereas hepatitis C induced mortality may be through extrahepatic diseases.
期刊介绍:
The journal aims to influence practice in medicine and its associated sciences through the publication of papers on statistical and other quantitative methods. Papers will explain new methods and demonstrate their application, preferably through a substantive, real, motivating example or a comprehensive evaluation based on an illustrative example. Alternatively, papers will report on case-studies where creative use or technical generalizations of established methodology is directed towards a substantive application. Reviews of, and tutorials on, general topics relevant to the application of statistics to medicine will also be published. The main criteria for publication are appropriateness of the statistical methods to a particular medical problem and clarity of exposition. Papers with primarily mathematical content will be excluded. The journal aims to enhance communication between statisticians, clinicians and medical researchers.